STOCK TITAN

IQVIA Launches New A.I.-Powered MI Contact Center For Life Sciences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

IQVIA (NYSE:IQV) has enhanced its Medical Information (MI) Contact Center services by integrating AI-powered technologies. This upgrade aims to improve response times and the overall experience for consumers, healthcare professionals (HCPs), and patients globally. The MI services now feature virtual agents working alongside human agents, enabling 24/7 support and efficient management of inquiries and adverse events. With operations in over 170 countries and support in 50 languages, IQVIA's advancements are set to bolster brand loyalty and trust in the life sciences industry.

Positive
  • Integration of AI-powered agents enhances response times and efficiency.
  • 24/7 availability and rapid scalability to meet demand surges.
  • Supports over 170 countries and operates in 50 direct languages.
Negative
  • None.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA™ (NYSE:IQV), a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced it has added new AI-powered technologies to enhance its existing Medical Information (MI) Contact Center services.

Life science companies use IQVIA’s MI Contact Center services to share information about new products and related therapeutic areas as well as monitor product quality and safety. This is done through teams of skilled agents responding directly to inquiries from consumers, patients, and healthcare professionals (HCPs) around the world. These teams also capture information related to adverse events and other product complaints, routing these through the appropriate compliance processes.

IQVIA’s MI Contact Center services now deploy AI-powered virtual agents alongside skilled human agents to triage and respond to inquiries. This combination of AI-powered agents and human agents creates faster response times and reporting of adverse events or quality concerns. It also allows for rapid scalability to meet surges in demand and efficient 24/7/365 availability. Overall, this new approach will improve the patient and HCP experience and strengthen brand loyalty.

“Adding new digital capabilities to our existing MI services marks a critical point in the industry as companies seek to balance the delivery of unbiased information to meet the needs of HCPs and patients,” said Annette Williams, vice president, IQVIA Lifecycle Safety. “IQVIA’s Medical Information services integrate across our Safety and Quality offerings, equipping clients with the end-to-end technology and services they need to increase trust, loyalty, and efficiencies for their patients.”

IQVIA’s MI Contact Center services are available in more than 170 countries with highly skilled agents responding to inquiries in 50 direct languages.

For more information on IQVIA Medical Information services, please visit: www.iqvia.com/medinfo.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 72,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, to advance their path toward cures. To learn more, visit www.iqvia.com.

Tor Constantino, IQVIA Media Relations (tor.constantino@iqvia.com)

+1.484.567.6732



Nick Childs, IQVIA Investor Relations (Nchilds@us.imshealth.com)

+1.973.316.3828

Source: IQVIA

FAQ

What recent updates has IQVIA made to its Medical Information Contact Center services?

IQVIA has integrated AI-powered technologies to enhance response times and improve service efficiency in its Medical Information Contact Center.

How does IQVIA's new technology affect patient and HCP interactions?

The AI integration allows for faster responses to inquiries, improving the experience for patients and healthcare professionals.

In how many countries does IQVIA provide its Medical Information services?

IQVIA's Medical Information services are available in over 170 countries worldwide.

What languages does IQVIA's MI Contact Center support?

IQVIA's MI Contact Center supports inquiries in 50 direct languages.

How does IQVIA plan to improve brand loyalty with its new AI technologies?

By enhancing efficiency and response times, the new AI technologies aim to strengthen trust and loyalty among patients and healthcare professionals.

IQVIA Holdings Inc.

NYSE:IQV

IQV Rankings

IQV Latest News

IQV Stock Data

35.96B
179.82M
0.92%
94.4%
1.44%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States of America
DURHAM